170 related articles for article (PubMed ID: 20170711)
41. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention.
Roth CL; Hinney A; Schur EA; Elfers CT; Reinehr T
BMC Pediatr; 2013 Nov; 13():197. PubMed ID: 24283216
[TBL] [Abstract][Full Text] [Related]
42. Genetic variations in dopamine and inhibitory control: lack of influence on action restraint.
Gurvich CT; Rossell SL
Behav Brain Res; 2014 Jul; 267():12-6. PubMed ID: 24657591
[TBL] [Abstract][Full Text] [Related]
43. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
44. Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability.
Shumay E; Fowler JS; Wang GJ; Logan J; Alia-Klein N; Goldstein RZ; Maloney T; Wong C; Volkow ND
Transl Psychiatry; 2012 Mar; 2(3):e86. PubMed ID: 22832851
[TBL] [Abstract][Full Text] [Related]
45. Smoking Genes: A Case-Control Study of Dopamine Transporter Gene (
Ruzilawati AB; Islam MA; Muhamed SKS; Ahmad I
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287325
[TBL] [Abstract][Full Text] [Related]
46. Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese.
Lan J; Song M; Pan C; Zhuang G; Wang Y; Ma W; Chu Q; Lai Q; Xu F; Li Y; Liu L; Wang W
J Hum Genet; 2009 Aug; 54(8):457-60. PubMed ID: 19590515
[TBL] [Abstract][Full Text] [Related]
47. HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.
Jacobs MM; Murray J; Byrd DA; Hurd YL; Morgello S
J Neurovirol; 2013 Oct; 19(5):495-504. PubMed ID: 24078558
[TBL] [Abstract][Full Text] [Related]
48. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers.
Erblich J; Lerman C; Self DW; Diaz GA; Bovbjerg DH
Mol Psychiatry; 2005 Apr; 10(4):407-14. PubMed ID: 15381926
[TBL] [Abstract][Full Text] [Related]
49. No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males.
Tsai SJ; Cheng CY; Shu LR; Yang CY; Pan CW; Liou YJ; Hong CJ
Psychiatr Genet; 2002 Mar; 12(1):29-33. PubMed ID: 11901357
[TBL] [Abstract][Full Text] [Related]
50. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of potential gene-gene interactions for attention deficit hyperactivity disorder in the Han Chinese population.
Qian Q; Wang Y; Li J; Yang L; Wang B; Zhou R; Glatt SJ; Faraone SV
Am J Med Genet B Neuropsychiatr Genet; 2007 Mar; 144B(2):200-6. PubMed ID: 17044099
[TBL] [Abstract][Full Text] [Related]
52. The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits.
Kazantseva A; Gaysina D; Malykh S; Khusnutdinova E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1033-40. PubMed ID: 21354244
[TBL] [Abstract][Full Text] [Related]
53. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
[TBL] [Abstract][Full Text] [Related]
54. Aggression and polymorphisms in AR, DAT1, DRD2, and COMT genes in Datoga pastoralists of Tanzania.
Butovskaya ML; Vasilyev VA; Lazebny OE; Suchodolskaya EM; Shibalev DV; Kulikov AM; Karelin DV; Burkova VN; Mabulla A; Ryskov AP
Sci Rep; 2013 Nov; 3():3148. PubMed ID: 24193094
[TBL] [Abstract][Full Text] [Related]
55. The Interaction of Dopamine Genes and Financial Stressors to Predict Adulthood Intimate Partner Violence Perpetration.
Schwab-Reese LM; Parker EA; Peek-Asa C
J Interpers Violence; 2020 Mar; 35(5-6):1251-1268. PubMed ID: 29294665
[TBL] [Abstract][Full Text] [Related]
56. An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.
Tong JH; Cummins TD; Johnson BP; McKinley LA; Pickering HE; Fanning P; Stefanac NR; Newman DP; Hawi Z; Bellgrove MA
Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):89-96. PubMed ID: 25656223
[TBL] [Abstract][Full Text] [Related]
57. Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium.
van Munster BC; Yazdanpanah M; Tanck MW; de Rooij SE; van de Giessen E; Sijbrands EJ; Zwinderman AH; Korevaar JC
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):38-45. PubMed ID: 19309018
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review.
van der Zwaluw CS; Engels RC; Buitelaar J; Verkes RJ; Franke B; Scholte RH
Pharmacogenomics; 2009 May; 10(5):853-66. PubMed ID: 19450132
[TBL] [Abstract][Full Text] [Related]
59. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
[TBL] [Abstract][Full Text] [Related]
60. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
Spellicy CJ; Kosten TR; Hamon SC; Harding MJ; Nielsen DA
Pharmacogenet Genomics; 2013 Jul; 23(7):333-40. PubMed ID: 23635803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
